Latest Breaking News On - Covishield manufacturer - Page 1 : comparemela.com

Covishield: Manufacturer, dose schedule, efficacy rate, possible side effects and price India Updated: Saturday, January 16, 2021, 15:26 [IST] New Delhi, Jan 16: Covishield vaccine has been developed by the University of Oxford and British-Swedish pharmaceutical company AstraZeneca. Adar Poonawalla, Chief Executive Officer, Serum Institute of India (SII) which is British-Swedish pharma giant AstraZeneca s manufacturing partner - said that the vaccine would be 90 to 95 per cent effective if the two shots are parted by around 2-3 months. File Photo The vaccine is being touted as one of the most promising vaccines for India where cost and logistics play a big roll. You ll be hearing some good news from the UK very soon. It would be a 90-95 per cent effective vaccine if you just keep a two-to-three months gap between dose 1 and dose 2. They will make that public with documentation.

United kingdomNew delhiAstrazeneca oxfordBriti roy barmanAdar poonawallaUniversity of oxfordSerum institute of indiaExpert committeeBriti royChief executive officerSerum instituteController generalSubject expert committeeBreaking newsInstant updatesCovishield manufacturer